Acoustic Tumors: Viewpoint—Stereotactic Radiotherapy

[1]  M. Levivier,et al.  Dosimetric comparison of different treatment modalities for stereotactic radiosurgery of arteriovenous malformations and acoustic neuromas. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  P. Cayé-Thomasen,et al.  Fractionated stereotactic radiotherapy of vestibular schwannomas accelerates hearing loss. , 2012, International journal of radiation oncology, biology, physics.

[3]  S. Merchant,et al.  Dysfunction of the Cochlea Contributing to Hearing Loss in Acoustic Neuromas: An Underappreciated Entity , 2012, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[4]  D. Roos,et al.  Stereotactic radiosurgery for acoustic neuromas: what happens long term? , 2012, International journal of radiation oncology, biology, physics.

[5]  M. Link,et al.  Long-term tumor control and cranial nerve outcomes following γ knife surgery for larger-volume vestibular schwannomas. , 2012, Journal of neurosurgery.

[6]  E. Balagamwala,et al.  Principles of Radiobiology of Stereotactic Radiosurgery and Clinical Applications in the Central Nervous System , 2012, Technology in cancer research & treatment.

[7]  H. Iizuka,et al.  Factors associated with hearing preservation after Gamma Knife surgery for vestibular schwannomas in patients who retain serviceable hearing. , 2011, Journal of neurosurgery.

[8]  John R Adler,et al.  Multisession Stereotactic Radiosurgery for Vestibular Schwannomas: Single-Institution Experience With 383 Cases , 2011, Neurosurgery.

[9]  J. Verheul,et al.  Management of large vestibular schwannoma. Part II. Primary Gamma Knife surgery: radiological and clinical aspects. , 2011, Journal of neurosurgery.

[10]  John Y. K. Lee,et al.  Predictors of Hearing Loss After Gamma Knife Radiosurgery for Vestibular Schwannomas: Age, Cochlear Dose, and Tumor Coverage , 2011, Neurosurgery.

[11]  J. Suh,et al.  Radiotherapy for vestibular schwannomas: a critical review. , 2011, International journal of radiation oncology, biology, physics.

[12]  B. Arthurs,et al.  A review of treatment modalities for vestibular schwannoma , 2011, Neurosurgical Review.

[13]  G. Barnett,et al.  Long-term outcomes of Gamma Knife radiosurgery in patients with vestibular schwannomas. , 2011, Journal of neurosurgery.

[14]  Oliver Jäkel,et al.  Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial , 2010, BMC Cancer.

[15]  Zhibin Huang,et al.  A Generalized Linear-Quadratic Model for Radiosurgery, Stereotactic Body Radiation Therapy, and High–Dose Rate Brachytherapy , 2010, Science Translational Medicine.

[16]  S. Lee,et al.  Outcomes of 75 patients over 12 years treated for acoustic neuromas with linear accelerator-based radiosurgery , 2010, Journal of Clinical Neuroscience.

[17]  W. Vandertop,et al.  Stereotactic radiation therapy for large vestibular schwannomas. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  J. Flickinger,et al.  Radiation therapy and hearing loss. , 2010, International journal of radiation oncology, biology, physics.

[19]  P. Cayé-Thomasen,et al.  Long-Term Hearing Preservation in Vestibular Schwannoma , 2010, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[20]  L. Pitts,et al.  The natural history of untreated sporadic vestibular schwannomas: a comprehensive review of hearing outcomes. , 2010, Journal of neurosurgery.

[21]  R. Jain,et al.  Hearing improvement after bevacizumab in patients with neurofibromatosis type 2. , 2009, The New England journal of medicine.

[22]  M. Link,et al.  Failure rate of contemporary low-dose radiosurgical technique for vestibular schwannoma. , 2009, Journal of neurosurgery.

[23]  R. Akagami,et al.  Prospective comparison of quality of life before and after observation, radiation, or surgery for vestibular schwannomas. , 2009, Journal of neurosurgery.

[24]  D. Kondziolka,et al.  Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma. , 2009, Journal of neurosurgery.

[25]  James J. Evans,et al.  Toward dose optimization for fractionated stereotactic radiotherapy for acoustic neuromas: comparison of two dose cohorts. , 2009, International journal of radiation oncology, biology, physics.

[26]  L. Pitts,et al.  Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: A systematic review , 2009, Journal of clinical neuroscience.

[27]  P. Herman,et al.  Conservative management of 386 cases of unilateral vestibular schwannoma: tumor growth and consequences for treatment. , 2009, Journal of neurosurgery.

[28]  J. Régis,et al.  HEARING PRESERVATION AFTER GAMMA KNIFE RADIOSURGERY FOR VESTIBULAR SCHWANNOMAS PRESENTING WITH HIGH‐LEVEL HEARING , 2009, Neurosurgery.

[29]  V. Kouloulias,et al.  Long-term results of LINAC-based stereotactic radiosurgery for acoustic neuroma: the Greek experience. , 2009, Journal of cancer research and therapeutics.

[30]  Charles Tator,et al.  Conservative management of vestibular schwannomas: third review of a 10‐year prospective study , 2008, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[31]  Lech Papiez,et al.  Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[32]  D. Andrews,et al.  Acoustic Neuromas and Other Benign Tumors: Fractionated Stereotactic Radiotherapy Perspective , 2008 .

[33]  L. Chin,et al.  Principles and practice of stereotactic radiosurgery , 2008 .

[34]  B. Clark,et al.  Hearing preservation following fractionated stereotactic radiotherapy for vestibular schwannomas: prognostic implications of cochlear dose. , 2007, Journal of neurosurgery.

[35]  Douglas A. Chen.  Acoustic Neuroma in a Private Neurotology Practice: Trends in Demographics and Practice Patterns , 2007, The Laryngoscope.

[36]  D. Wikler,et al.  Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome. , 2007, Journal of neurosurgery.

[37]  D. Kondziolka,et al.  Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12 to 13 Gy. , 2007, International journal of radiation oncology, biology, physics.

[38]  S. Selesnick,et al.  LINAC radiosurgery and radiotherapy treatment of acoustic neuromas. , 2007, Otolaryngologic clinics of North America.

[39]  C. Ménard,et al.  Fractionated stereotactic radiotherapy for acoustic neuroma , 2007, Cancer.

[40]  James J. Evans,et al.  A review of 3 current radiosurgery systems. , 2006, Surgical neurology.

[41]  D. Liguoro,et al.  Twenty years' experience in the treatment of acoustic neuromas with fractionated radiotherapy: a review of 45 cases. , 2006, International journal of radiation oncology, biology, physics.

[42]  J. Mandrekar,et al.  Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. , 2006, Neurosurgery.

[43]  D. Welling,et al.  The Molecular Biology of Vestibular Schwannomas: Dissecting the Pathogenic Process at the Molecular Level , 2006, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[44]  D. Kraus,et al.  Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma , 2005, Cancer.

[45]  Faith G Davis,et al.  Descriptive epidemiology of vestibular schwannomas. , 2006, Neuro-oncology.

[46]  J. Debus,et al.  Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a single institution. , 2005, International journal of radiation oncology, biology, physics.

[47]  Y. Kida,et al.  Stereotactic Radiosurgery for Vestibular Schwannomas: Analysis of 317 Patients Followed More Than 5 Years , 2005, Neurosurgery.

[48]  Chul-Kee Park,et al.  Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma , 2005, Cancer.

[49]  P. Black,et al.  Stereotactic Radiotherapy for Vestibular Schwannomas: Favorable Outcome with Minimal Toxicity , 2005, Neurosurgery.

[50]  A. Panarese,et al.  Conservative management of sporadic unilateral acoustic neuromas , 2005, The Journal of Laryngology & Otology.

[51]  R. T. Ten Haken,et al.  Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. , 2005, International journal of radiation oncology, biology, physics.

[52]  E. Smouha,et al.  Conservative Management of Acoustic Neuroma: A Meta‐Analysis and Proposed Treatment Algorithm , 2005, The Laryngoscope.

[53]  D. Shrieve,et al.  Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance , 2004 .

[54]  P. Cayé-Thomasen,et al.  Increasing annual incidence of vestibular schwannoma and age at diagnosis , 2004, The Journal of Laryngology & Otology.

[55]  D. Kondziolka,et al.  Acoustic neuroma radiosurgery with marginal tumor doses of 12 to 13 Gy. , 2003, International journal of radiation oncology, biology, physics.

[56]  A. Thornton,et al.  Correlative studies of cochlear neuronal loss with speech discrimination and pure-tone thresholds , 2004, Archives of oto-rhino-laryngology.

[57]  J. C. Baayen,et al.  Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a single-institution study. , 2003, International journal of radiation oncology, biology, physics.

[58]  M. Linskey,et al.  Radiation exposure of normal temporal bone structures during stereotactically guided gamma knife surgery for vestibular schwannomas. , 2003, Journal of neurosurgery.

[59]  W. Curran,et al.  Fractionated Stereotactic Radiotherapy for the Treatment of Optic Nerve Sheath Meningiomas: Preliminary Observations of 33 Optic Nerves in 30 Patients with Historical Comparison to Observation with or without Prior Surgery , 2002, Neurosurgery.

[60]  J. Buatti,et al.  Analysis of risk factors associated with radiosurgery for vestibular schwannoma. , 2001, Journal of neurosurgery.

[61]  W. Curran,et al.  Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution. , 2001, International journal of radiation oncology, biology, physics.

[62]  D A Morgan,et al.  The role of biologically effective dose (BED) in clinical oncology. , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

[63]  R. Dale,et al.  Mathematical models of tumour and normal tissue response. , 1999, Acta oncologica.

[64]  S. Selesnick,et al.  Radiologic surveillance of acoustic neuromas. , 1998, The American journal of otology.

[65]  G. Pendl,et al.  Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. , 1998, Journal of neurosurgery.

[66]  M Samii,et al.  Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. , 1997, Neurosurgery.

[67]  D. Kondziolka,et al.  Dose and diameter relationships for facial, trigeminal, and acoustic neuropathies following acoustic neuroma radiosurgery. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[68]  B W Corn,et al.  Characteristics of a dedicated linear accelerator-based stereotactic radiosurgery-radiotherapy unit. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[69]  R. Coffey,et al.  Stereotactic radiosurgery using the gamma knife for acoustic neuromas. , 1995, International journal of radiation oncology, biology, physics.

[70]  F. Bova,et al.  Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. , 1994, International journal of radiation oncology, biology, physics.

[71]  Harold F. Schuknecht,et al.  Auditory and Cytocochlear Correlates of Inner Ear Disorders , 1994, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[72]  D. Kondziolka,et al.  Gamma knife radiosurgery for acoustic tumors: multivariate analysis of four year results. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[73]  D. Larson,et al.  Optic neuropathy after irradiation of meningioma. , 1992, Radiology.

[74]  K. Winston,et al.  Linear accelerator as a neurosurgical tool for stereotactic radiosurgery. , 1988, Neurosurgery.

[75]  G. Gardner,et al.  Hearing Preservation in Unilateral Acoustic Neuroma Surgery , 1988, The Annals of otology, rhinology, and laryngology.

[76]  H. Schuknecht,et al.  Ganglion cell populations in normal and pathological human cochleae. Implications for cochlear implantation. , 1978, The Laryngoscope.

[77]  L. Leksell.  A note on the treatment of acoustic tumours. , 1971, Acta chirurgica Scandinavica.